0

Transfection Technologies Market Research Report, Size , Growth, Trends, Opportunity Analysis, Industry Forecast - 2022-2026

  • Published: Sep 2022
  • Pages: 120
  • SKU: IRTNTR74402
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The transfection technologies Market is projected to grow by USD 526.14 million with a CAGR of 9.05%, during the forecast period 2021 to 2026.

This transfection technologies market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers transfection technologies market segmentation by end-user (pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes) and geography (North America, Asia, Europe, and the Rest of the World (ROW)). The transfection technologies market report also offers information on several market vendors, including Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc. among others.

What will the Transfection Technologies Market Size be During the Forecast Period?

Transfection Technologies Market Size

Download Report Sample to Unlock the Transfection Technologies Market Size for the Forecast Period and Other Important Statistics

 

Transfection Technologies Market: Key Drivers, Trends, and Challenges

The availability of innovative products is notably driving the transfection technologies market growth, although factors such as the lack of promotional activities may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the transfection technologies industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Transfection Technologies Market Driver

One of the key factors driving the transfection technologies market growth is the availability of innovative products. Vendors in the market are offering products with improved features to create their mark in the market, retain existing consumers, and attract prospective consumers. For instance, Neon Transfection System from Thermo Fisher Scientific is offered as a second-generation transfection system using an electronic pipette tip as an electroporation chamber. Its electroporation chamber can be used as a pipette. Its circular shape offers a significant advantage over cuvette-based systems. Furthermore, the design of the chamber allows the equal distribution of current between the cells, thereby maintaining a stable pH throughout the chamber, which increases cell viability. Such product offerings aid in attracting prospective consumers, leading to both increased sales and high volume production among vendors, which will propel the growth of the global transfection technologies market during the forecast period.

Key Transfection Technologies Market Trend

Increased use of dual-reporter assays and co-transfection experiments are a major trend influencing the transfection technologies market's growth. With the rise in biological and pharmaceutical research, there has been a rise in the use of dual-reporter systems due to their advantages over single reporter systems. A dual-reporter system allows expression to be normalized for cell number and transfection efficiency. With the use of a dual-reporter system, it is easy to determine if the effects are due to the treatment of the cells or a response from the experimental reporter. For instance, the Dual-Glo Luciferase Assay System from Promega allows the determination of the luminescent signal from two reporter genes in the same sample. The effective results offered and the fact that they can cut down on the costs of consumables will popularize the use of dual-reporter assays in the market. This advantage will lead to a rise in the adoption of dual-reporter assays and co-transfection experiments, leading to market growth.

Key Transfection Technologies Market Challenge

Lack of promotional activities is one of the key challenges hindering the transfection technologies market. The nature of the products makes it difficult for vendors to promote them. By establishing a marketing plan, vendors can ensure the success and sustainability of their businesses. For instance, social media can be used to promote content, establish online communities, and support lead generation activities. Vendors such as Promega have published online videos on YouTube to attract potential end-users. Other vendors need to follow suit to garner larger market shares and ensure improved product viability. Publishing a series of blogs and newsletters would help guide quality traffic to the company's website. This would allow vendors to sustain long-term marketing campaigns and encourage visitors to return. However, inadequate promotional activities will negatively impact market growth during the forecast period and prevent vendors from establishing a sizeable customer base.

This transfection technologies market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global transfection technologies market as a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the transfection technologies market during the forecast period.

Who are the Major Transfection Technologies Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Altogen Biosystems
  • Bio Rad Laboratories Inc.
  • Biontex Laboratories GmbH
  • Boca Scientific Inc.
  • F. Hoffmann La Roche Ltd.
  • GENLANTIS
  • Inovio Pharmaceuticals Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Mirus Bio LLC
  • OZ Biosciences
  • POLYPLUS TRANSFECTION S.A
  • Promega Corp.
  • PromoCell GmbH
  • QIAGEN NV
  • SignaGen Laboratories
  • Takara Holdings Inc
  • Thermo Fisher Scientific Inc.

 

This statistical study of the transfection technologies market encompasses successful business strategies deployed by the key vendors. The transfection technologies market is fragmented, and the vendors are adopting growth strategies such as organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Bio Rad Laboratories Inc.- The company offers transfection technology such as transfection lipid reagents.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The transfection technologies market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies

Transfection Technologies Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the transfection technologies market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profits and also the optimization and evaluation of business strategies The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.

The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Transfection Technologies Market?

Transfection Technologies Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

42% of the market’s growth will originate from North America during the forecast period. The US is the key market for transfection technologies market in North America. Market growth in this region will be slower than the growth of the market in Asia.

Increasing investments in new manufacturing facilities equipped with bioprocessing units and other equipment required for processes such as cell line development and cell culture will facilitate the transfection technologies market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID-19 Impact and Recovery Analysis

The outbreak of COVID-19 in 2020 affected all countries in North America, especially the US. The outbreak had a slight negative impact on clinical trials and donors for regenerative medicines in the region. A rise in the number of COVID-19 cases in the first quarter of 2020 led to the imposition of partial lockdowns in several countries, including Canada and Mexico. Thus, various non-urgent pharmaceutical operations, such as analytical testing, which could be halted or postponed, were either conducted in a limited capacity or halted as per the set guidelines. However, transfection technologies have been found to have potential uses in the treatment of COVID-19, as they aim at repairing, regenerating, and restoring the missing functions of organ cells. Thus, studying the interactions between the SARS-CoV-2 virus and host cells can be beneficial. Moreover, the lifting of lockdowns, the resumption of clinical trials, and the implementation of vaccination drives will lead to demand for transfection technologies in North America. Therefore, the regional market will likely register growth during the forecast period.

What are the Revenue-generating End-user Segments in the Transfection Technologies Market?

Transfection Technologies Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The transfection technologies market share growth in the pharmaceutical and biotechnology companies segment will be significant during the forecast period. With the growing prevalence of chronic diseases worldwide, there is a growing need for pharmaceutical and biotechnology companies to manufacture high-quality and regulatory-compliant drugs and therapeutics. 

Besides the above-mentioned factors, the post-COVID-19 impact has brought forth a slowdown in or fast-tracked the demand for services or products. This report provides an accurate prediction of the contribution of all the segments to the growth of the transfection technologies market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Transfection Technologies Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 9.05%

Market growth 2022-2026

$526.14 million

Market structure

Fragmented

YoY growth (%)

8.02

Regional analysis

North America, Asia, Europe, and the Rest of the World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Canada, Germany, China, Japan, and India

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Transfection Technologies Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive transfection technologies market growth during the next five years
  • Precise estimation of the transfection technologies market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the transfection technologies industry across North America, Asia, Europe, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of transfection technologies market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
    • 5.2 Comparison by End-user
      • Exhibit 26: Chart on Comparison by End-user
      • Exhibit 27: Data Table on Comparison by End-user
    • 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
    • 5.4 Contract research organizations - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
    • 5.5 Academic and research institutes - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by End-user
      • Exhibit 40: Market opportunity by End-user ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.5 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 China - Market size and forecast 2021-2026
      • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.9 Japan - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.10 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 India - Market size and forecast 2021-2026
      • Exhibit 82: Chart on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on India - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on India - Year-over-year growth 2021-2026 (%)
    • 7.13 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 Bio Rad Laboratories Inc.
              • Exhibit 93: Bio Rad Laboratories Inc. - Overview
              • Exhibit 94: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 95: Bio Rad Laboratories Inc. - Key news
              • Exhibit 96: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 97: Bio Rad Laboratories Inc. - Segment focus
            • 10.4 Lonza Group Ltd.
              • Exhibit 98: Lonza Group Ltd. - Overview
              • Exhibit 99: Lonza Group Ltd. - Business segments
              • Exhibit 100: Lonza Group Ltd. - Key news
              • Exhibit 101: Lonza Group Ltd. - Key offerings
              • Exhibit 102: Lonza Group Ltd. - Segment focus
            • 10.5 Merck KGaA
              • Exhibit 103: Merck KGaA - Overview
              • Exhibit 104: Merck KGaA - Business segments
              • Exhibit 105: Merck KGaA - Key news
              • Exhibit 106: Merck KGaA - Key offerings
              • Exhibit 107: Merck KGaA - Segment focus
            • 10.6 Mirus Bio LLC
              • Exhibit 108: Mirus Bio LLC - Overview
              • Exhibit 109: Mirus Bio LLC - Product / Service
              • Exhibit 110: Mirus Bio LLC - Key news
              • Exhibit 111: Mirus Bio LLC - Key offerings
            • 10.7 OZ Biosciences
              • Exhibit 112: OZ Biosciences - Overview
              • Exhibit 113: OZ Biosciences - Product / Service
              • Exhibit 114: OZ Biosciences - Key offerings
            • 10.8 POLYPLUS TRANSFECTION S.A
              • Exhibit 115: POLYPLUS TRANSFECTION S.A - Overview
              • Exhibit 116: POLYPLUS TRANSFECTION S.A - Product / Service
              • Exhibit 117: POLYPLUS TRANSFECTION S.A - Key news
              • Exhibit 118: POLYPLUS TRANSFECTION S.A - Key offerings
            • 10.9 Promega Corp.
              • Exhibit 119: Promega Corp. - Overview
              • Exhibit 120: Promega Corp. - Product / Service
              • Exhibit 121: Promega Corp. - Key offerings
            • 10.10 QIAGEN NV
              • Exhibit 122: QIAGEN NV - Overview
              • Exhibit 123: QIAGEN NV - Product / Service
              • Exhibit 124: QIAGEN NV - Key news
              • Exhibit 125: QIAGEN NV - Key offerings
            • 10.11 SignaGen Laboratories
              • Exhibit 126: SignaGen Laboratories - Overview
              • Exhibit 127: SignaGen Laboratories - Product / Service
              • Exhibit 128: SignaGen Laboratories - Key offerings
            • 10.12 Thermo Fisher Scientific Inc.
              • Exhibit 129: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 131: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 134: Inclusions checklist
                • Exhibit 135: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 136: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 137: Research methodology
                • Exhibit 138: Validation techniques employed for market sizing
                • Exhibit 139: Information sources
              • 11.5 List of abbreviations
                • Exhibit 140: List of abbreviations
              • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
                • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                  Research Framework

                  Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                  TechnavioINFORMATION SOURCES

                  Primary sources

                  • Manufacturers and suppliers
                  • Channel partners
                  • Industry experts
                  • Strategic decision makers

                  Secondary sources

                  • Industry journals and periodicals
                  • Government data
                  • Financial reports of key industry players
                  • Historical data
                  • Press releases
                  Technavio

                  TechnavioDATA ANALYSIS

                  Data Synthesis

                  • Collation of data
                  • Estimation of key figures
                  • Analysis of derived insights

                  Data Validation

                  • Triangulation with data models
                  • Reference against proprietary databases
                  • Corroboration with industry experts
                  Technavio

                  TechnavioREPORT WRITING

                  Qualitative

                  • Market drivers
                  • Market challenges
                  • Market trends
                  • Five forces analysis

                  Quantitative

                  • Market size and forecast
                  • Market segmentation
                  • Geographical insights
                  • Competitive landscape
                  Interested in this report?
                  Get your sample now!
                  Transfection Technologies market growth will increase by $526.14 million during 2022-2026.
                  The transfection technologies market is expected to grow at a CAGR of 9.05% during 2022-2026.
                  Technavio has segmented the transfection technologies market by geographic (North America, Asia, Europe, and Rest of World (ROW)).
                  Altogen Biosystems, Bio Rad Laboratories Inc., Biontex Laboratories GmbH, Boca Scientific Inc., F. Hoffmann La Roche Ltd., GENLANTIS, Inovio Pharmaceuticals Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, POLYPLUS TRANSFECTION S.A, Promega Corp., PromoCell GmbH, QIAGEN NV, SignaGen Laboratories, Takara Holdings Inc, Thermo Fisher Scientific Inc. are a few of the key vendors in the transfection technologies market.
                  North America will register the highest growth rate of 41.94% among the other regions. Therefore, the transfection technologies market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
                  The key factors driving the transfection technologies market growth are:
                  • Rising demand for monoclonal antibodies
                  • Increased use of dual-reporter assays and co-transfection experiments
                  The transfection technologies market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
                  • What are the key global market and the regional market share?
                  • What are the revenue-generating key market segments?
                  • What are the key factors driving and challenging this market’s growth?
                  • Who are the key market vendors and their growth strategies?
                  • What are the latest trends influencing the growth of this market?
                  • What are the variables influencing the market growth in the primary regions?
                  • What are the factors influencing the growth of the parent market?
                  • Off-the-shelf research reports
                  • Reports can be tailored to meet the customer's needs
                  • Trusted by more than 100 fortune 500 organizations
                  • Information about the market's key drivers, trends, and challenges
                  • Parent market analysis
                  • Every week, 50,000 people visit our subscription platform
                  • Detailed vendors report with competitive landscape
                  • Covid-19 impact and recovery analysis
                  • Data on revenue-generating market segments
                  • Details on the market shares of various regions
                  • Five-force market analysis

                  Certified ISO 9001 : 2015

                  We are ISO recognized

                  We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                  We are GDPR and CCPA compliant

                  We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                  Safe and Secure SSL Encrypted
                  Technavio

                  info
                  close
                  • Single:

                    One user only.
                    Quick & easy download option

                  • Enterprise:

                    Unlimited user access (Within your organization)
                    Complimentary Customization Included

                  2500 USD

                  Technavio Get the report (PDF) sent to your email within minutes.

                  Subscribe & Save

                  Get lifetime access to our
                  Technavio Insights

                  Customized Report as per your Business Needs

                  • Our analysts will work directly with you and understand your needs
                  • Get data on specified regions or segments, competitor and Vendors
                  • Data will be formatted and presented as per your requirements
                  • We offer $1000 worth of FREE customization at the time of purchase

                  Let us help you make report more suited to your requirements.

                  • Get a competitive breakdown as per your niche industry
                  • Customize the data with various metrics that meet your business prerequisite
                  • Understand Revenue Sources, Customers and many more
                  • Details on Market Share
                  • These customizations are done in a short amount of time by our analysts and industry experts
                  Technavio
                  Enquire Before Buying
                  17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>